President Donald Trump has delayed implementing threatened 100% tariffs on branded pharmaceutical products as his administration pursues negotiated drug pricing agreements with major manufacturers, according to White House officials. The administration paused its plan to enact the duties, originally scheduled
Amgen has announced a $650 million expansion of its US manufacturing network, creating nearly 750 new jobs at its biologics manufacturing facility in Juncos, Puerto Rico. The investment will support increased drug production and integrate advanced technologies throughout the operations
Novartis has built up substantial pharmaceutical stockpiles in the United States and announced major manufacturing investments as the Swiss company prepares for potential tariffs under President Trump’s trade policies, CEO Vas Narasimhan revealed on Saturday. Speaking to Swiss newspaper Neue
